Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Inclusion Criteria: * \- The mentioned bellow patients caused by the following bacteria which are sensitive to this drug: Indicated microorganisms:Staphylococcus, Enterococcus, Bacillus anthracis, Escherichia coli, Klebsiella , Enterobacter, Pseudomonas aeruginosa, Legionella. Indications: Sepsis, Secondary skin infections (superficial burn, operative wounds, trauma), Pneumonia, Peritonitis, Cholecystitis, Cholangitis, Anthrax * The patients treated with this drug without dilution due to strict restriction of fluid intake. * In hospitalized patients who retain consciousness ,and at the same time who are able to report (such as vascular pain) side effects.. Exclusion Criteria: * Patients who are contraindicated based on the product label.